• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

XOMA:GR

2.969 EUR 0.061 2.01%

As of 04:55:03 ET on 07/25/2014.

Snapshot for XOMA Corp (XOMA)

Open: 2.970 Day's Range: 2.969 - 3.029 Volume: 0
Previous Close: 3.030 52wk Range: 2.436 - 7.000 1-Yr Rtn: -25.61%

Stock Chart for XOMA

No chart data available.
  • XOMA:GR 2.969
  • 1D
  • 1M
  • 1Y
3.030
Interactive XOMA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for XOMA

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -0.7150
Est. PEG Ratio -
Market Cap (M EUR) 317.38
Shares Outstanding (M) 106.90
30 Day Average Volume 616
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/07/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for XOMA

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for XOMA

XOMA Corporation is a biopharmaceutical company that develops and manufactures genetically engineered protein, peptide, and antibody pharmaceuticals. The Company's medical targets include bacterial and fungal infections, infectious complications, and immunologic and inflammatory disorders. XOMA's primary drug development platform is bactericidal/permeability-increasing protein.

John VarianChief Executive OfficerPatrick J ScannonExec VP/Chief Biotechnology Ofcr
Paul D RubinSenior VP:Research & DevTom KleinVP/Chief Commercial Officer
More Company Profile & Key Executives for XOMA

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil